Advertisement
Screener

MANNKIND CORP (MNKD) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.9 / 5 stars · 48/83 Roast Me

MANNKIND CORP Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

MANNKIND CORP (MNKD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 68.79 million shares for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-07.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-02-26

  • MANNKIND CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 68.79M shares, a 5.93% decline year-over-year.
  • MANNKIND CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-06-30 was 73.13M shares.
  • MANNKIND CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 71.90M shares, a 2.02% decline year-over-year.
  • MANNKIND CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 73.38M shares, a 4.13% increase year-over-year.
  • MANNKIND CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 63.75M shares, a 15.51% decline from fiscal 2022.
  • MANNKIND CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 75.45M shares, a 7.79% increase from fiscal 2021.
  • MANNKIND CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 70.00M shares, a 113.77% increase from fiscal 2020.
  • MANNKIND CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 32.75M shares, a 17.48% decline from fiscal 2019.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2024-06-3068.79M shares
10-Q · filed 2024-08-07
2023-12-3163.75M shares
10-K · filed 2026-02-26
2023-09-3077.09M shares
10-Q · filed 2024-11-07
2023-06-3073.13M shares
10-Q · filed 2024-08-07		73.13M shares
10-Q · filed 2024-08-07
2023-03-3171.90M shares
10-Q · filed 2024-05-08
2022-12-3175.45M shares
10-K · filed 2025-02-26
2022-09-3071.92M shares
10-Q · filed 2023-11-07
2022-06-3073.34M shares
10-Q · filed 2023-08-07
2022-03-3173.38M shares
10-Q · filed 2023-05-09
2021-12-3170.00M shares
10-K · filed 2024-02-27
2021-09-3071.33M shares
10-Q · filed 2022-11-08		71.33B shares
10-Q · filed 2021-11-09
2021-06-3072.10M shares
10-Q · filed 2022-08-09		72.10B shares
10-Q · filed 2021-08-11
2021-03-3170.47M shares
10-Q · filed 2022-05-05		70.47B shares
10-Q · filed 2021-05-12
2020-12-3132.75M shares
10-K · filed 2023-02-23
2020-09-3038.56B shares
10-Q · filed 2021-11-09		38.56M shares
10-Q · filed 2020-11-04
2020-06-3032.85B shares
10-Q · filed 2021-08-11		32.85M shares
10-Q · filed 2020-08-05
2020-03-3138.80B shares
10-Q · filed 2021-05-12		38.80M shares
10-Q · filed 2020-05-06
2019-12-3139.68M shares
10-K · filed 2021-02-25
2019-09-3056.83M shares
10-Q · filed 2020-11-04
2019-06-3069.28M shares
10-Q · filed 2020-08-05
2019-03-3178.54M shares
10-Q · filed 2020-05-06
2018-12-3178.21M shares
10-K · filed 2020-02-25
2018-09-3052.27M shares
10-Q · filed 2019-11-08
2018-06-3062.93M shares
10-Q · filed 2019-08-07
2018-03-3141.33M shares
10-Q · filed 2019-05-07
2017-12-3115.27M shares
10-K · filed 2019-02-26
2017-09-309.32M shares
10-Q · filed 2017-11-07		9.32M shares
10-Q · filed 2018-11-01
2017-06-3019.72M shares
10-Q · filed 2018-08-02
2017-03-3117.24M shares
10-Q · filed 2018-05-09		17.21M shares
10-Q · filed 2017-05-10
2016-12-3116.83M shares
10-K · filed 2019-02-26		16.79M shares
10-K · filed 2017-03-16
2016-09-3015.62M shares
10-Q · filed 2017-11-07		78.09M shares
10-Q · filed 2016-11-09		16.43M shares
10-Q · filed 2017-11-07		82.16M shares
10-Q · filed 2016-11-09
2016-06-3017.11M shares
10-Q · filed 2017-08-07		85.55M shares
10-Q · filed 2016-08-09
2016-03-316.46M shares
10-Q · filed 2017-05-10		32.28M shares
10-Q · filed 2016-05-09
2015-12-315.98M shares
10-K · filed 2018-02-27		29.73M shares
10-K · filed 2016-03-15
2015-09-3030.42M shares
10-Q · filed 2016-11-09		30.42M shares
10-Q · filed 2016-11-09
2015-06-3040.98M shares
10-Q/A · filed 2016-08-10
2015-03-3145.17M shares
10-Q · filed 2016-05-09
2014-12-3110.29M shares
10-K · filed 2017-03-16		51.46M shares
10-K · filed 2015-03-02
2014-09-3047.82M shares
10-Q · filed 2015-11-09
2014-06-3056.84M shares
10-Q · filed 2015-08-10
2014-03-3167.79M shares
10-Q · filed 2015-05-11
2013-12-3178.48M shares
10-K · filed 2016-03-15
2013-09-30133.94M shares
10-Q · filed 2014-11-10
2013-06-30129.43M shares
10-Q · filed 2014-08-11
2013-03-31133.50M shares
10-Q · filed 2014-05-12
2012-12-31128.32M shares
10-K · filed 2015-03-02
2012-09-3063.83M shares
10-Q · filed 2013-11-12
2012-06-3061.74M shares
10-Q · filed 2013-08-09
2012-03-3154.31M shares
10-Q · filed 2013-05-10
2011-12-3134.05M shares
10-K · filed 2014-03-03
2011-09-3033.90M shares
10-Q · filed 2012-11-09
2011-06-3032.05M shares
10-Q · filed 2012-08-09
2010-12-3130.86M shares
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Advertisement